Photo via FreightWaves
According to FreightWaves, UPS has committed $48 million to expand its cold chain infrastructure, adding 27 new chilled transfer facilities designed for pharmaceutical and other temperature-sensitive shipments. The facilities are engineered to optimize speed and provide short-term storage capacity, addressing growing demand in the critical healthcare logistics segment.
The investment underscores UPS's strategic push to capture a larger share of the high-value pharmaceutical distribution market, where maintaining precise temperature controls is essential for product integrity and regulatory compliance. Cold chain logistics has become increasingly vital as global pharmaceutical shipments—including biologics, vaccines, and specialty medications—continue to expand.
By bolstering its refrigerated transfer network, UPS aims to enhance its competitive positioning against rivals and meet the specialized requirements of healthcare companies and contract manufacturers that depend on reliable, temperature-controlled shipping solutions.
